Journal of Thrombosis and Haemostasis, 1538-7933

Tidskrift

Fler filtreringsmöjligheter
  1. 2007
  2. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice

    Annika Jögi, Pass, J., Hoyer-Hansen, G., Lund, L. R., Nielsen, B. S., Dano, K. & Romer, J., 2007, I : Journal of Thrombosis and Haemostasis. 5, 9, s. 1936-1944

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients

    Borel-Derlon, A., Federici, A. B., Roussel-Robert, V., Goudemand, J., Lee, C. A., Scharrer, I., Rothschild, C., Erik Berntorp, Henriet, C., Tellier, Z., Bridey, F. & Mannucci, P. M., 2007, I : Journal of Thrombosis and Haemostasis. 5, 6, s. 1115-1124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.

    Lethagen, S., Kyrle, P. A., Castaman, G., Haertel, S. & Mannucci, P. M., 2007, I : Journal of Thrombosis and Haemostasis. 5, Apr 16, s. 1420-1430

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2008
  6. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    Budde, U., Schneppenheim, R., Eikenboom, J., Goodeve, A., Will, K., Drewke, E., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Perez, A., Meyer, D., Mazurier, C., Goudemand, J., Ingerslev, J., Habart, D., Vorlova, Z., Holmberg, L., Lethagen, S., Pasi, J. & 2 andraHill, F. & Peake, I., 2008, I : Journal of Thrombosis and Haemostasis. 6, 5, s. 762-771

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats

    Lauritzen, B., Hedner, U., Johansen, P. B., Tranholm, M. & Ezban, M., 2008, I : Journal of Thrombosis and Haemostasis. 6, 5, s. 804-811

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2009
  9. An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and aPTT

    Ulf Schött, Rundgren, M. & Engström, M., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 871-872 PP-WE-721.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  10. Autologous plasma for the study of anaphylatoxinkinetics in man

    Ulf Schött & Norda, R., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, PP-MO-672.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  11. Bedside point of care coagulation testing forindividualized antivitamin K reversal in emergencysurgery

    Ulf Schött, Winstedt, D. & Anveden, P., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 1167 1 s., PP-TH-695.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  12. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

    Collins, P. W., Blanchette, V. S., Fischer, K., Bjorkman, S., Oh, M., Fritsch, S., Schroth, P., Spotts, G., Jan Astermark & Ewenstein, B., 2009, I : Journal of Thrombosis and Haemostasis. 7, 3, s. 413-420

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Can proteins induced by vitamin K absence - PIVKA-II - detect subclinical vitamin k deficit in major surgery?

    Ulf Schött, Anveden, P., Strandberg, K., Flisberg, P., Engström, M. & Hillarp, A., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 404 PP-MO-258.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  14. Comparison of two different heparin doses inperipheral vascular surgery

    Ulf Schött & DAG WINSTEDT, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, PP-TH-359.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  15. Comparison of two infusionrates of antithrombinconcentrate in cardiopulmonary bypass surgery

    Ulf Schött, Carlsson, T. & Lund, P., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 1075 1 s., PP-TH-428.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  16. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis

    Lindqvist, P. G., Epstein, E. & Håkan Olsson, 2009, I : Journal of Thrombosis and Haemostasis. 7, 4, s. 605-610

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A

    Pavlova, A., Delev, D., Lacroix-Desmazes, S., Schwaab, R., Mende, M., Fimmers, R., Jan Astermark & Oldenburg, J., 2009, I : Journal of Thrombosis and Haemostasis. 7, 12, s. 2006-2015

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Prothrombin complex concentrate and effects on thecone and plate analyser

    Ulf Schött, Jirgård, L., Strandberg, K. & Hillarp, A., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 885 1 s., PP-WE-758.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  19. The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?

    Marx, P. F., Plug, T., Havik, S. R., Mörgelin, M. & Meijers, J. C. M., 2009, I : Journal of Thrombosis and Haemostasis. 7, 3, s. 445-452

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2010
  21. APC-PCI complex as new tool for the evaluation of anticoagulant response to endogenous thrombin formation and its sequel in fibrinolysis

    Kluft, C., Johan Stenflo, Meijer, P. & Burggraaf, J., 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 58-58

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  22. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Seron, V. M., Marx, P. F., Marquart, J. A., Heiko Herwald, de Groot, P. G. & Meijers, J. C. M., 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 20-21

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  23. Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

    Gopalakrishnan, R., Hedner, U., Ghosh, S., Nayak, R. C., Allen, T. C., Pendurthi, U. R. & Rao, L. V. M., 2010, I : Journal of Thrombosis and Haemostasis. 8, 2, s. 301-310

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.

    Carl Ekman, Stenhoff, J. & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, 4, s. 838-844

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.

    Andreas Hillarp, Stadler, M., Haderer, C., Weinberger, J., Kessler, C. M. & Römisch, J., 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 2216-2223

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.

    Tran, S. & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, 1, s. 129-136 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. rFVIIa transported from the blood stream into tissues is functionally active

    Gopalakrishnan, R., Hedner, U., Clark, C., Pendurthi, U. R. & Rao, L. V. M., 2010, I : Journal of Thrombosis and Haemostasis. 8, 10, s. 2318-2321

    Forskningsoutput: TidskriftsbidragLetter

  28. The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.

    Oslakovic, C., Jauhiainen, M., Ehnholm, C. & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 766-772

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 2011
  30. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).

    Gringeri, A., Björn Lundin, Mackensen, S. V., Mantovani, L. & Mannucci, P. M., 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 700-710

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

    Andreas Hillarp, Baghaei, F., Blixter, I. F., Gustafsson, K. M., Stigendal, L., Sten-Linder, M., Strandberg, K. & Lindahl, T. L., 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 133-139

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.

    van Os, G. M. A., Meijers, J. C. M., Ağar, C., Valls Serón, M., Marquart, J. A., Per Åkesson, Urbanus, R. T., Derksen, R. H. W. M., Heiko Herwald, Mörgelin, M. & de Groot, P. G., 2011, I : Journal of Thrombosis and Haemostasis. 9, 12, s. 2447-2456

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    Agersø, H., Brophy, D. F., Pelzer, H., Martin, E. J., Carr, M., Hedner, U. & Ezban, M., 2011, I : Journal of Thrombosis and Haemostasis. 9, 2, s. 333-338

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).

    Tiede, A., Friedrich, U., Stenmo, C., Allen, G., Giangrande, P., Goudemand, J., Hay, C., Holmström, E. M., Klamroth, R., Lethagen, S., McKenzie, S., Miesbach, W., Negrier, C., Yuste, V. J. & Erik Berntorp, 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 1191-1199

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Högberg, C., Olof Gidlöf, Tan, C., Svensson, S., Öhman, J., David Erlinge & Björn Olde, 2011, I : Journal of Thrombosis and Haemostasis. 9, 2, s. 361-372

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Wide temperature range testing with sonoclot plateletfunction and ROTEM EXTEM/FIBTEM/APTEM test

    Ulf Schött, Brokopp, J., Mårtensson, J., Attila Frigyesi & Hans Friberg, 2011, I : Journal of Thrombosis and Haemostasis. 9, s2, s. 91 1 s., P-MO-104.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  37. Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden

    R. Ljung & ANNIKA MÅRTENSSON, 2011 jul 1, I : Journal of Thrombosis and Haemostasis. 9, s. 462 1 s., P-TU-492.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  38. 2012
  39. Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.

    Knoebl, P., Paese, M., Baudo, F., Collins, P., Huth-Kühne, A., Nemes, L., Pellegrini, F., Lilian Tengborn & Lévesque, H., 2012, I : Journal of Thrombosis and Haemostasis. 10, 4, s. 622-631

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    Clark, C. A., Vatsyayan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, I : Journal of Thrombosis and Haemostasis. 10, 11, s. 2383-2391

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?

    Hermans, C., Jan Astermark & De Moerloos, P., 2012, I : Journal of Thrombosis and Haemostasis. 10, 10, s. 2194-2196

    Forskningsoutput: TidskriftsbidragLetter

  42. Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

    Kristinsson, S. Y., Goldin, L., Ingemar Turesson, Hultcrantz, M., Björkholm, M. & Landgren, O., 2012, I : Journal of Thrombosis and Haemostasis. 10, 5, s. 962-964

    Forskningsoutput: TidskriftsbidragLetter

  43. Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

    Gopalakrishnan, R., Pendurthi, U. R., Hedner, U., Agersø, H., Esmon, C. T. & Rao, L. V. M., 2012, I : Journal of Thrombosis and Haemostasis. 10, 5, s. 971-973

    Forskningsoutput: TidskriftsbidragLetter

  44. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).

    Pabinger, I., Vossen, C. Y., Lang, J., Conard, J., García-Dabrio, M. C., Miesbach, W., Legnani, C., Peter Svensson, Kaider, A. & Rosendaal, F. R., 2012, I : Journal of Thrombosis and Haemostasis. 10, 2, s. 217-222

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Origin of Swedish hemophilia A mutations

    Halldén, C., Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2012, I : Journal of Thrombosis and Haemostasis. 10, 12, s. 2503-2511

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    Collins, P. W., Møss, J., Knobe, K., Groth, A., Colberg, T. & Watson, E., 2012, I : Journal of Thrombosis and Haemostasis. 10, 11, s. 2305-2312

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. 2013
  48. 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.

    Rolf Ljung, Karim, F. A., Saxena, K., Suzuki, T., Arkhammar, P., Rosholm, A. & Giangrande, P., 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1260-1268

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Origin of Swedish hemophilia B mutations

    Hallden, C., Annika Mårtensson, Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2013, I : Journal of Thrombosis and Haemostasis. 11, 11, s. 2001-2008

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.

    Milladur Rahman, Zhang, S., Chew, M., Ingvar Syk, Bengt Jeppsson & Henrik Thorlacius, 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1385-1398

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. 2014
  52. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1935-1939

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

    Andreas Hillarp, Gustafsson, K. M., Faxälv, L., Strandberg, K., Baghaei, F., Fagerberg Blixter, I., Berndtsson, M. & Lindahl, T. L., 2014, I : Journal of Thrombosis and Haemostasis. 12, 9, s. 1545-1553

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

    Hultcrantz, M., Pfeiffer, R. M., Bjorkholm, M., Goldin, L. R., Ingemar Turesson, Schulman, S., Landgren, O. & Kristinsson, S. Y., 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1816-1821

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    Eckhardt, C. L., Jan Astermark, Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, I : Journal of Thrombosis and Haemostasis. 12, 8, s. 1294-1301

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. 2015
  57. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.

    Hansson, K. M., Gustafsson, D., Skärby, T., Frison, L. & Erik Berntorp, 2015, I : Journal of Thrombosis and Haemostasis. 13, 7, s. 1293-1300

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift